BlueCrest Capital Management’s Cantel Medical Corporation CMD Stock Holding History

BlueCrest Capital Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-47,268	Closed	-$4.35M	–	1611
2018 Q3	$4.35M	Sell	47,268 -22,493	-32%	-$2.14M	0.12%	123
2018 Q2	$6.86M	Buy	69,761 +64,681	+1,273%	+$7.23M	0.18%	120
2018 Q1	$566K	Buy	+5,080	New	+$569K	0.02%	705
2017 Q4	–	Sell	-8,065	Closed	-$759K	–	1182
2017 Q3	$759K	Buy	+8,065	New	+$637K	0.03%	422
2016 Q4	–	Sell	-4,168	Closed	-$325K	–	943
2016 Q3	$325K	Buy	+4,168	New	+$302K	0.01%	601

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BlueCrest Capital Management's CMD Position: Q4 2018 in Review

BlueCrest Capital Management sold out of Cantel Medical Corporation (CMD) in Q4 2018, closing a stake of 47,268 shares — an estimated $4.35M sold.

BlueCrest Capital Management first reported a position in CMD in Q3 2016 and held it in 5 quarters. The position peaked at $6.86M in Q2 2018. 253 funds tracked by Wall St. Rank hold CMD as of Q4 2018.

BlueCrest Capital Management reported no remaining Cantel Medical Corporation position as of Q4 2018 after selling out during the quarter.
BlueCrest Capital Management sold 47,268 Cantel Medical Corporation shares in Q4 2018, an estimated $4.35M.
BlueCrest Capital Management first reported a position in Cantel Medical Corporation in Q3 2016 and held it in 5 quarters.
BlueCrest Capital Management's Cantel Medical Corporation position peaked at $6.86M in Q2 2018.
253 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.